1. Outcomes of Additional Treatment for Patients With Infiltrative Hepatocellular Carcinoma 
Lance L. Stein, MD, Marty T. Sellers, MD, MPH 
Clinical Gastroenterology and Hepatology 
Volume 11, Issue 12, (December 2013)
DOI: /j.cgh
Copyright © 2013 AGA Institute Terms and Conditions

2. Figure 1
Survival of iHCC patients undergoing DEB-TACE vs DEB-TACE + sorafenib (Child–Pugh A and B).
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2013 AGA Institute Terms and Conditions